Skip to content

Biventricular Alternative Pacing

Better Pacing - Biventricular Pacing as Alternative Method in Patients With Disturbances of AV Conduction and Preserved LV Function

Status
Withdrawn
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00559143
Acronym
BETTER
Enrollment
38
Registered
2007-11-16
Start date
2007-11-30
Completion date
2011-07-31
Last updated
2011-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Atrioventricular Block

Keywords

AV conduction disturbances, LV function, Biventricular Pacing, Conductance Catheters

Brief summary

Aim of present study is to examine the short and long-term results of pacing from right ventricular apex and to compare them with those of biventricular pacing.

Detailed description

In this study all subjects to be studied will have atrioventricular conduction disturbances that require permanent artificial pacing. In all subjects a biventricular pacemaker will be implanted. Moreover the subjects will be randomized in a biventricular or conventional pacing mode and will be observed for a long term period.

Interventions

OTHERBiventricular Pacing (DDD(R)- BiV)

Subjects indicated for DDD(R) pacing due to AV conduction disturbances and preserved LV function will receive biventricular pacing DDD(R)- BiV

Sponsors

Medtronic Hellas Medical Devices ΑEE
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Subjects between the age of 18 to 75 years with classic indication for permanent artificial pacing in which it is expected very high percentage of ventricular pacing, (pacing systoles constitute the 80% and more of the total). * Physiologic or mildly affected systolic function of left ventricle, LVEF\> 40%. * Subject is willing and able to comply with the Clinical Investigational Plan and to remain available for follow-up visits, through study closure. * Subject (or if allowed by local law/regulations: subject's legally authorised representative) is willing and able to sign and date the study Informed Consent.

Exclusion criteria

* Subjects with classic indication for Biventricular Pacing - (European Guidelines 2007). * Permanent atrial fibrillation. * Cardiovascular surgery within the last three months prior to enrollment. * Myocardial infarction within the last three months prior to enrollment.

Design outcomes

Primary

MeasureTime frame
Change in End Diastolic Diameter of Left Ventricle with the two different ways of pacing (DDD(R)-RV & DDD(R)-BiV)two years

Secondary

MeasureTime frame
Tolerance in the cardiopulmonary stress test, quality of life, LV function and changes of BNP, TNF, interleukin-6, interleukin-12 and oxidant stress.two years
Assessment of the operation of Left Ventricle at the different pacing types using conductance catheters in a subgroup of patients that will perform a programmed coronary angiography due to investigation of possible coronary artery disease.two years

Countries

Greece

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026